Recent TXG News
- TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative • PR Newswire (US) • 10/31/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/29/2024 08:10:00 PM
- 10x Genomics Reports Third Quarter 2024 Financial Results • PR Newswire (US) • 10/29/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 08:04:16 PM
- 10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches • PR Newswire (US) • 10/15/2024 08:05:00 PM
- Tesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits; 10x Genomics Stock Drops on Revenue Forecast • IH Market News • 10/10/2024 10:45:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 08:07:17 PM
- 10x Genomics Announces Preliminary Select Third Quarter 2024 Results • PR Newswire (US) • 10/09/2024 08:05:00 PM
- 10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting • PR Newswire (US) • 10/01/2024 08:05:00 PM
- Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer • PR Newswire (US) • 09/10/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 09:34:30 PM
- 10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research • PR Newswire (US) • 09/03/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:05:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:04:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:03:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 12:45:27 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 12:42:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 12:39:54 AM
- 10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference • PR Newswire (US) • 08/22/2024 08:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:35:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:12:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:08:00 PM
- 10x Genomics Announces Senior Leadership Changes • PR Newswire (US) • 08/08/2024 08:05:00 PM
- 10x Genomics Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:04:00 PM
- 10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases • PR Newswire (US) • 08/05/2024 08:00:00 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM